Breaking Barriers Symposium

FORMERLY THE BREAKING BARRIERS SUMMIT

Are you a licensed nurse, counselor, social worker, physician or other care professional?
Are you a committed health advocate?
The Breaking Barriers Symposium is an experience not to miss.

Outside of the timely content and dynamic presenters,
you can participate for FREE and from anywhere.

The 2021 Breaking Barriers Symposium will be presented virtually over two days.
MAY 26 & MAY 27, 20201
(EVENT MEDIA RELEASE)

To increase convenience for those who may not be able to share both days with us,
each day requires a separate registration.

VISIT SEAETC.COM/CALENDAR FOR MORE DETAILS!


Presented by the Alabama AIDS Education Training Center (Alabama AETC)
and Medical Advocacy & Outreach (MAO)


Breaking Barriers Symposium: DAY ONE

HIV in Alabama

May 26, 2021
9 AM – 3 PM (CST)

Professional Development: Webcast
Continuing Education: 4.25 contact hours possible

Registration: FREE REGISTRATION (includes audio/video learning experience, course materials and Certificate of Attendance with contact hours)

Partial credit will not be offered. Additional instructions associated with confirmation of credit may be provided at the time of training. All participants may be required to complete more than one evaluation/assessment.

Agenda (Subject to change.):

9:00 – 10:00 AM
Ending the HIV Epidemic in Alabama, Laurie Dill MD, AAHIVS
(keynote speaker)

KEYNOTE SPEAKER
MAY 26, 2021

Laurie Dill, MD, AAHIVS
For many actively engaged in the field of HIV care, Dr. Dill requires little introduction. Dill served as Medical Director for Medical Advocacy and Outreach (MAO) from 2006 through 2019, although her expertise, passion and involvement with MAO and its patients truly began in 1996 when she came onboard as a physician. Dr. Dill, an Alabama native, received her undergraduate degree from Vanderbilt University and attended medical school and residency at the University of Alabama at Birmingham Medical School. She is Board Certified in Internal Medicine in addition to being certified as an HIV Specialist by the American Academy of HIV Medicine. In her career, she has undertaken medical mission work in Belize, worked as an Instructor in Medicine at the Johns Hopkins University School of Medicine as part of their Faculty Development Program, and served as the County Health Officer of the Montgomery County Health Department. Her influence extends far outside of Alabama, having presented in many settings including her talk on HIV and Women in the South to the 45th Meeting of the President’s Advisory Council on HIV/AIDS (PACHA) in Washington D.C. Dr. Dill has co-authored articles on Domestic Violence in primary care. She helped implement MAO’s service model including the successful integration of a nationally recognized telemedicine program. In 2016, Dr. Dill was named as one of POZ Magazine’s POZ 100, and in 2017, Dr. Dill was presented with The Samaritan Counseling Center’s Maury D. Smith Award for Excellence in Professional Ethics. In 2019, she was honored by the University of Alabama Medical Alumni Association with the Martha Myers Role Model Award. At the end of 2019, Dr. Dill passed the mantle of Medical Director for MAO to Dr. Cordelia Stearns and transitioned into the critical position of MAO’s Liaison on the Ending the HIV Epidemic Initiative. When not engaged in policy and strategic work, she continues to support the care needs of patients throughout South Alabama.

Learning Objectives
• Discuss and overview of the Ending the HIV Epidemic (EtHE): A Plan for America and the 4 pillars of the plan.
• Discuss Alabama’s baseline and the specific goals for Alabama in the EtHE Initiative plan.
• Discuss the tools for ending the epidemic, including universal opt-out HIV testing
• Highlight PrEP, the MAO ePrEP program, and how PrEP is integrated into the Care Continuum

10:00 – 10:15 AM – Virtual Coffee Break

10:15 – 11:15 AM
Innovations in Care, Michael Murphree, LICSW

Learning Objectives
• Participants will receive information on the issues facing rural communities in specialty care delivery.
• Participants will learn about the use of Telemedicine/Telehealth in the Medical Advocacy and Outreach service area and how to address HIPAA concerns.
• Participants will develop an understanding of potential costs for implementing a Telemedicine/Telehealth project in a resource-limited area.

11:15 – 11:30 AM – Virtual Coffee Break

11:30 AM – 12:30 PM
Using Big Data to Inform HIV Testing Interventions, Lynn Matthews, MD, MPH

Learning Objectives
• Understand time to diagnosis and HIV testing patterns in Alabama.
• Understand County-level factors associated with testing rates and time to diagnosis
• Describe opportunities for increasing access to testing in Alabama

12:30 – 1:30 PM – Virtual Lunch Break

1:30 – 3:00 PM
Trauma-Informed Care in the South, Panel Discussion
Shakita Brooks-Jones, MSW, MPA (Moderator)

Panel Members: Tommy Chavis, LPC, Tony Walker, Tori Cooper, Marguerite Barber-Owens MD, AAHIVS

Learning Objectives
• To increase provider and staff knowledge in HIV clinical settings about how to discuss and approach sensitive and traumatic topics with consumers.
• To enhance HIV providers’ ability to develop better rapport and relationships with consumers.
• To educate about the impact Trauma-Informed Care has on sexual risks and community-based education and testing.
• To discuss the importance of HIV clinical settings creating safe spaces and developing safety and crisis plans.
• To increase awareness of how beliefs and lack of knowledge impact Trauma-Informed Care practices in the South.

3 PM – Closing Remarks, Bretia Gordon, Ed.D., MPA


Breaking Barriers Symposium: DAY TWO

COVID-19 in Alabama

May 27, 2021
9 AM – 3 PM (CST)

Professional Development: Webcast
Continuing Education: 4.25 contact hours possible

Registration: FREE REGISTRATION (includes audio/video learning experience, course materials and Certificate of Attendance with contact hours)

Partial credit will not be offered. Additional instructions associated with confirmation of credit may be provided at the time of training. All participants may be required to complete more than one evaluation/assessment.

Agenda (Subject to change.):

9:00 – 10:00 AM
COVID-19 in Vulnerable Populations, Michael Saag, MD

(keynote speaker)

KEYNOTE SPEAKER
May 27, 2021

Michael Saag, MD
Michael S. Saag is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham. He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, Director of the Center for AIDS Research, and the Associate Dean of Global Health. Dr. Saag received a B.S. in chemistry with honors in 1977 Tulane University and earned his medical degree from the University of Louisville. During medical school, he served for three years on the Medical School Admissions Committee and received the Presley Martin Memorial Award for Excellence in Clinical Medicine. He completed his residency and infectious disease and molecular virology fellowship training at the University of Alabama at Birmingham. During his fellowship training, Dr. Saag made seminal discoveries in the genetic evolution of HIV in vivo. He evaluated isolates of virus obtained from individual patients at different periods in time and cloned and molecularly characterized these isolates to determine the degree of diversity of co-existing viral variants and to describe their evolution over time (Nature, 1988). While working with Dr. Dismukes, Dr. Saag designed and led a multi-center national AIDS clinical trial on the management of cryptococcal meningitis. This study included 194 patients and demonstrated the role of oral azole therapy in the treatment of this disorder in HIV-infected patients (NEJM, 1992). During the last 6 months of his fellowship, Dr. Saag conceived the concept of a comprehensive HIV outpatient (1917) clinic dedicated to the provision of comprehensive patient care in conjunction with the conduct of high quality clinic trials, basic science, and clinical outcomes research. Within the clinic structure, he established a clinical trials unit, a data management center, and a Clinical Specimen Repository designed to support the activities of the newly established Center for AIDS Research at UAB. In essence, the clinic became a “hub” for the clinical, basic science, and behavioral science investigators within the Center by creating a dynamic interface between the patients and the investigators.

Since the establishment of the clinic, Dr. Saag has participated in many studies of antiretroviral therapy as well as novel treatments for opportunistic infections. He has published over 260 articles in peer reviewed journals, including the first description of the use of viral load in clinical practice (Science, 1993), the first description of the rapid dynamics of viral replication (Nature, 1995), the first guidelines for use of viral load in practice (Nature Medicine, 1996), the first proof of concept of fusion inhibition as a therapeutic option (Nature Medicine, 1998), and directed the ‘first-in- patient’ studies of 7 of the 25 antiretroviral drugs currently on the market (including indinavir, efavirenz, abacavir, and enfuvirtide). Dr. Saag has contributed over 50 chapters to medical textbooks, has served on the Editorial Board of AIDS Research and Human Retroviruses, Co-Edited a textbook entitled AIDS Therapy (Churchill Livingston, now in its 3rd edition, and currently serves as an Editor of the Sanford Guide for Antimicrobial Agents and the Sanford HIV Guide. He recently served on the Board of Directors of the American Board of Internal Medicine (and as Chair of the Infectious Disease Subspecialty Board), has twice served as a member of the HIV Disease Committee of the Medical Knowledge Self-Assessment Program for the American College of Physicians, and has served recently on the NIH Office of AIDS Research Advisory Council. Dr. Saag currently serves on the International AIDS Society-USA Board of Directors, is President-elect of the HIV Medical Association, as a member of the HHS Guidelines Panel on Antiretroviral Therapy, and on numerous state, local, and national committees. He was elected into the American Society of Clinical Investigation in 1997. Among his other awards, Dr. Saag has received the Myrtle Wreath Award from Hadassah, was listed as one of the top ten cited HIV researchers by Science (1996), and has been listed as one of the Best Doctors in America since 1994. He received the Outstanding Medical Research Achievement Award from the AIDS Task Force of Alabama, an Excellence in Teaching Award from the Medical Association of the State of Alabama, was named a “Health Care Hero” by the Birmingham Business Journal (2003), received a Service Award from the AIDS Survival Project in Atlanta (2003), was a 2004 honoree of the Birmingham Chapter of the National Conference on Community and Justice (NCCJ), a recipient of the Birmingham Chamber of Commerce Spirit of Birmingham Award (2005), was a recipient of the Leonard Tow Humanism in Medicine Award (The Arnold P. Gold Foundation), and was a recipient of the UAB Alumni Society Hettie Butler Terry Community Service Award (2007).

Learning Objectives
• Pending revision.

10:00 – 10:15 AM – Virtual Coffee Break

10:15 – 11:15 AM
COVID-19 Vaccine Updates, Cordelia Stearns, MD, AAHIVS

Learning Objectives
• Define authorized and recommended COVID-19 vaccines in the United States.
• Discuss COVID-19 vaccine information for specific groups.
• Outline the benefits of COVID-19 vaccination including herd immunity.

11:15 – 11:30 AM – Virtual Coffee Break

11:30 AM – 12:30 PM
Impact of COVID-19 on HIV Linkage and Prevention, Latesha Elopre, MD, MSPH & Anthony Merriweather, MSPH

Learning Objectives
• Describe the latest research on COVID-19 infection among people with HIV.
• Discuss the impact of the COVID-19 pandemic on the provision of HIV testing and care.
• Review outpatient triage and management of HIV patients with COVID-19 infection.
• Provide an overview of Health Equity and Social Determinants of Health.
• Describe Health Equity Implications for HIV and COVID-19
• Provide Solutions for the field work
• Provide an overview of Sexually Transmitted Diseases in Alabama.
• Describe the impact of COVID-19 on STD prevention services and linkages to treatment
• Discuss the correlation between COVID-19 and STD contact tracing.
• Explain the importance of disease control in preventing communicable and infectious diseases

12:30 – 1:30 PM – Virtual Lunch Break

1:30 – 3:00 PM
The Impact of COVID-19 on Behavioral Health, Elana M. Parker Merriweather, Ed.S., AADC, BCC, BC-TBH

Learning Objectives
• Provide an overview of COVID-19 and behavioral health care services in Ryan White care settings.
• Discuss the impact of COVID-19 on mental health issues including depression, PTSD, dementia, ADHD, grief, and suicide.
• Explain the influence of “twindemics” on recipients with co-occurring disorders.
• List practical leadership tips that can be used with behavioral health service providers

3 PM – Closing Remarks, Bretia Gordon, Ed.D., MPA


Continuing Education Considerations

THE FOLLOWING STATEMENTS APPLY TO EACH DAY OF THE BREAKING BARRIERS SYMPOSIUM. Each day you participate, you can earn up to 4.25 contact hours if you are a nurse, counselor or social worker, or up to 4.0 if you are a MD.

For Counselors, Social Workers and Nurses:

Counselors: Medical Advocacy & Outreach (MAO) has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6882. Programs that do not qualify for NBCC credit are clearly identified. MAO is solely responsible for all aspects of the programs. This activity has been approved for up to 4.25 contact hour for counselors.

Social Workers: Medical Advocacy and Outreach (MAO) has been approved by the Alabama Board of Social Work Examiners as a provider of Continuing Education for social workers, Provider No. 0134. Exp. 3/31/2023. This activity has been approved for up to 4.25 contact hours (clinical) for social workers.

Nurses: Medical Advocacy & Outreach is an approved continuing education provider of the Alabama Board of Nursing, ABNP 1554, exp. 10/24/2024. This activity has been approved for up to 4.25 contact hours for nurses.

To receive credit, learners must complete the requirements listed here.

-Use your full name and email address when logging in to view the webcast. This is how your name will be recorded for possible CE credit.
-Where prompted, provide your discipline, state, and license number, if applicable. Failure to provide complete and accurate information will delay issuance of CE credit. For Alabama nurses, this is critical.
-Remain logged in for the duration of the presentation. Partial credit will not be offered.
-Learners who join more than ten (10) minutes late or log out more than ten (10) minutes early will NOT be eligible to claim CE credit.
-If you dial in by phone you must also be logged on from a computer or other device that allows you to view the slides and participate in the chat and Q&A portion of the activity.

Following the presentation, a continuing education contact hours certificate/certificate of completion will be emailed to all attendees who successfully complete the requirements for earning credit. Nurses licensed in Alabama will have credit applied to their account within two (2) weeks of the activity.

For questions regarding Continuing Education, please email aandersen@maoi.org.

For Physicians:

Meharry Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Meharry Medical College designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/CME REQUEST LINK

Please use the link above only if your credentials are MD.